Resumen

CORREA-ROTTER, Ricardo et al. Consesus document in the use of SGLT inhibitors in patients with diabetes and chronic kidney disease. Gac. Méd. Méx [online]. 2022, vol.158, n.spe2, pp.M1-M12.  Epub 16-Mayo-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000595.

Chronic kidney disease (CKD) in the diabetic patient is mainly a consequence of long-term diabetes mellitus itself. In Mexico approximately 50% of patients on dialysis are diabetics and this will could increase in the coming years. New therapeutic options available, combined with lifestyle changes, have improved glycemic control and may contribute to delay the onset as well as the progression of CKD. International scientific societies have developed clinical guidelines for the diagnosis and management of CKD in diabetics, although in some points, these recommendations are not adapted to the Mexican reality. We hereby present the conclusions of the consensus reached by Mexican specialists on diabetic nephropathy.

Palabras llave : Chronic kidney disease; Type 2 diabetes; Recommendations; iSGLT2.